Detecting and stopping animal- and insect-transmitted infections in Uganda
Official title: CK19-001 - Identification, Surveillance, and Control of Vector-Borne and Zoonotic Infectious Diseases in Uganda
Funded at Uganda Virus Research Institute · NIH-11407517 · Data updated 2026-11-12
A program in Uganda to strengthen testing, tracking, and rapid response for infections passed from animals or insects to protect affected communities.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Uganda Virus Research Institute NIH-funded |
| Lab location | 1 site (Entebbe, Uganda) |
| Project start | September 1, 2019 |
| Project end | August 31, 2026 |
| Funding year | 2023 |
| Award (this year) | $700,000 |
| NIH project number | 6U01CK000564-05M003 |
| Project ID | NIH-11407517 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are people living in affected Ugandan districts, especially those with recent fever, animal contact, or exposure to ticks or mosquitoes, and those who work with livestock.
✕Less likely to help
People outside Uganda or those without exposure to animal- or insect-borne infections are unlikely to receive direct benefit from this program.
What this research studies
The program will strengthen laboratory testing, surveillance, and rapid response for infections such as Crimean–Congo hemorrhagic fever, Rift Valley fever, yellow fever, and Marburg. Field teams may collect blood samples from people and animals, trap and test insects, and map areas of higher risk. Data will be linked between laboratories and health services to detect outbreaks early and guide targeted actions like vaccination, treatment, or vector control. Community education and coordination with local health workers are included to help prevent further spread.
Why it matters
Potential benefit: If successful, the program could detect outbreaks earlier and reduce illness and deaths by guiding quicker, targeted responses.
How similar studies have gone: Similar surveillance and rapid-response programs have helped contain past outbreaks, though new or rare pathogens still present challenges.
Where this research is happening
-
Uganda Virus Research Institute
Entebbe, Uganda Active
Researchers
- Principal investigator: Lutwama, Julius Julian — Uganda Virus Research Institute
- Study coordinator: Lutwama, Julius Julian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.